Sung-Bae Cho
Director Ejecutivo en CHOA PHARMACEUTICAL CO., LTD. .
Fortuna: 875 295 $ al 30/04/2024
Perfil
Sung-Bae Cho is currently the President, Co-Chief Executive Officer & Director at ChoA Pharmaceutical Co., Ltd.
He previously worked as the Vice President at Medipharm.
Mr. Cho completed his undergraduate degree at Hanyang University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2023 | 750 000 ( 2.42% ) | 875 295 $ | 30/04/2024 |
Cargos activos de Sung-Bae Cho
| Empresas | Cargo | Inicio |
|---|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Director Ejecutivo | 17/10/2014 |
Antiguos cargos conocidos de Sung-Bae Cho.
| Empresas | Cargo | Fin |
|---|---|---|
Medipharm
 Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Corporate Officer/Principal | - |
Formación de Sung-Bae Cho.
| Hanyang University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Bolsa de valores
- Insiders
- Sung-Bae Cho